This disclosure relates to robotic surgical systems, e.g., for minimally invasive surgery including, but not limited to, endoluminal and single-site surgery.
Minimally invasive surgery such as endoluminal and single-site robotic surgery offer significant advantages versus traditional robotic surgery. For example, in endoluminal robotic surgery, no incision need be made to access difficult to access locations within a patient's natural lumen. This dramatically reduces and/or eliminates recovery time and improves procedural safety. A single-site system reduces incisions to a minimum single-site, which reduces an otherwise larger number of incisions to provide access for certain procedures.
Certain endoluminal and single-site robotic surgical systems have been proposed. Examples of such systems and related components can be found in U.S. Pat. No. 10,881,422, as well as U.S. Patent Application Nos. US20210322046, US20210322045, US20190117247, US20210275266, US20210267702, US20200107898, US20200397457, US202000397456, US20200315645, and US201962914226, all of the above being incorporated by reference herein in their entirety.
Conventional surgical robotics and systems have generally been considered satisfactory for their intended purpose. However, there is still a need in the art for improved robotic surgical systems, devices, methods, controls, and components, especially those configured for endoluminal and single-site surgery. The present disclosure provides improvements in such areas, for example.
In accordance with at least one aspect of this disclosure, a patient console for a robotic surgical system can include a base, a vertical lift attached to a top of the base and configured to provide up and down motion in a vertical axis, a yaw rotation device attached to the top of the vertical lift and configured to provide a yaw rotation about the vertical axis, a pitch rotation device attached to the top of the yaw rotation device and configured to provide a pitch rotation about a pitch axis orthogonal to the vertical axis, a translation device attached to the top of the pitch rotation device and configured to provide sliding translation along a translation axis, and a roll rotation device attached to the translation device to roll relative to the translation device about a roll axis to provide a roll to an instrument controller assembly. An angle of the translation axis and the roll axis relative to horizontal can be a function of the pitch rotation provided by the pitch rotation device. A direction of the translation axis and the roll axis can be a function of the yaw rotation provided by the yaw rotation device.
The patient console can include an instrument controller assembly connected to the roll rotation device, the instrument controller assembly including one or more instrument controllers for controlling a medical device for performing a surgical operation, wherein the vertical lift, the yaw rotation device, the pitch rotation device, the translation device, and the roll rotation device provide 5-degrees of freedom to the instrument controller assembly. In certain embodiments, the base can be configured to move relative to a floor to provide an additional degree of freedom of motion.
The patient console can be configured to allow for positioning of a medical device for a transanal procedure, a transoral procedure, or a transvaginal procedure. Any other suitable procedure is contemplated herein.
The patient console can include a user input device attached to the base and configured to control each of the vertical lift, the yaw rotation device, the pitch rotation device, the translation device, and the roll rotation device. The user input device can include a display having a graphical user interface (GUI) for controlling each of the vertical lift, the yaw rotation device, the pitch rotation device, the translation device, and the roll rotation device. The GUI can be configured to indicate an orientation and position of the instrument controller assembly from one or more angles. The GUI can be configured to have any suitable digital buttons, inputs, indicators, images, text, and/or other content.
In accordance with at least one aspect of this disclosure, a robotic surgical system, can include a patient console. The patient console can be any patient console disclosed herein, e.g., as described above.
In accordance with at least one aspect of this disclosure, a method for performing a robotic medical procedure can include using a vertical lift attached to a top of a base of a patient console to provide up and down motion in a vertical axis, using a yaw rotation device attached to the top of the vertical lift to provide a yaw rotation about the vertical axis, using a pitch rotation device attached to the top of the yaw rotation device and configured to provide a pitch rotation about a pitch axis orthogonal to the vertical axis, using a translation device attached to the top of the pitch rotation device and configured to provide sliding translation along a translation axis, and using a roll rotation device attached to the translation device to roll relative to the translation device about a roll axis to provide a roll to an instrument controller assembly. An angle of the translation axis and the roll axis relative to horizontal can be a function of the pitch rotation provided by the pitch rotation device. A direction of the translation axis and the roll axis can be a function of the yaw rotation provided by the yaw rotation device.
The method can include using an instrument controller assembly having one or more instrument controllers connected to the roll rotation device for controlling a medical device for performing a surgical operation, and using the vertical lift, the yaw rotation device, the pitch rotation device, the translation device, and the roll rotation device provide 5-degrees of freedom to the instrument controller assembly. The method can include moving the base of the patient console relative to a floor to provide an additional degree of freedom of motion. The method can include positioning a medical device for a transanal procedure, a transoral procedure, or a transvaginal procedure.
The method can include controlling each of the vertical lift, the yaw rotation device, the pitch rotation device, the translation device, and the roll rotation device with a user input device. The method can include using a graphical user interface (GUI) to control each of the vertical lift, the yaw rotation device, the pitch rotation device, the translation device, and the roll rotation device. The method can include any other suitable method(s) and/or portion(s) thereof.
These and other features of the embodiments of the subject disclosure will become more readily apparent to those skilled in the art from the following detailed description taken in conjunction with the drawings.
So that those skilled in the art to which the subject disclosure appertains will readily understand how to make and use the devices and methods of the subject disclosure without undue experimentation, embodiments thereof will be described in detail herein below with reference to certain figures, wherein:
Reference will now be made to the drawings wherein like reference numerals identify similar structural features or aspects of the subject disclosure. For purposes of explanation and illustration, and not limitation, an illustrative view of an embodiment of a system in accordance with the disclosure is shown in
Referring to
An angle of the translation axis A3 and the roll axis A4 relative to horizontal can be a function of the pitch rotation provided by the pitch rotation device 107. A direction of the translation axis A3 and the roll axis A4 can be a function of the yaw rotation provided by the yaw rotation device 105.
The console 100 can include an instrument controller assembly 113 connected to the roll rotation device 111, the instrument controller assembly 113 including one or more instrument controllers 115 for controlling a medical device (not shown) for performing a surgical operation. The vertical lift 103, the yaw rotation device 105, the pitch rotation device 107, the translation device 109, and the roll rotation device 111 can provide 5-degrees of freedom to the instrument controller assembly 113 (and thus the overtube 117 mounted thereon), for example. In certain embodiments, the base 101 can be configured to move relative to a floor to provide an additional degree of freedom of motion.
The patient console 100 can be configured to allow for positioning of a medical device for a transanal procedure, a transoral procedure, or a transvaginal procedure. Any other suitable procedure is contemplated herein.
The system 100 can include a user input device 119 attached to the base 101 and configured to control each of the vertical lift 103, the yaw rotation device 105, the pitch rotation device 107, the translation device 109, and the roll rotation device 111. Referring additionally to
In certain embodiments, one or more of the vertical lift 103, the yaw rotation device 105, the pitch rotation device 107, the translation device 109, and the roll rotation device 111 can be controlled by a remote surgeon console in addition to the user input device 119, for example. In certain embodiments, the user input device 119 can control all of the vertical lift 103, the yaw rotation device 105, the pitch rotation device 107, the translation device 109, and the roll rotation device 111, and a remote surgeon console can control the translation device 109 and the roll rotation device 111 only.
Embodiments can be used for robotic surgical systems, for example. Any suitable uses and/or embodiments for use are contemplated herein.
Embodiments include five degree of freedom positioning patient console 100 (e.g., a patient cart). Embodiments can include an advantageous order of stacking of the degrees of freedom.
Embodiments can provide movements for the position of the overtube 117 attached to the overtube arm 200. Embodiments can include five joints and each joint provides specific motion. In certain embodiments, joint 1 (e.g., J1 as shown in
In certain embodiments, all of the joints can be controlled by a nurse using the touchscreen on the patient console 100. Joint 4 and Joint 5 can be controlled by a surgeon by using the hand control devices and overtube pedal on the surgeon console (not shown).
Certain embodiments can include an interface (e.g. user input device 119) that has a touchscreen (e.g. the display 121), a base cart handle 123, and a stabilizer (not shown). Certain embodiments can allow control of the mobility of the patient console 100 system with drive control switches and the direction of force applied on the base cart handle 123. Certain embodiments can allow control via the base cart handle 123 is activated only when the drive control switches are pressed down halfway and held. Certain embodiments can be immobilized by activating the stabilizers via a touchscreen to prevent unwanted movement during surgery.
Embodiments of a user input device 119 can be used to control the positioning arm 102 and patient console 100. Embodiments of a user input device can indicate the status of the patient console 100. Embodiments of a user input device 119 can provide a setting menu for the base cart and its touchscreen. Embodiments of a user input device 119 can display buttons to control movements of the positioning arm 102.
Embodiments of a touchscreen GUI 700 can include a loading user interface that displays immediately when the power is on and initializes the patient console 100 and touchscreen. The GUI can include a home screen that provides access menu buttons to the Pose Setting, Patient Cart, and Diagnosis, for example. Embodiments of a GUI 700 can include a Patient Cart Setting Screen that provides detailed settings of the patient console 100 to adjust values related to mobility. The GUI 700 can include a Setting Screen that provides a setting menu to adjust the brightness of the touch screen. The GUI 700 can include a pose setting screen that provides touch buttons to adjust the pose setting of each joint of the positioning arm 102. In
An emergency stop indicator can show activation of the emergency stop. When the emergency stop is activated, the icon can be changed to orange and red colors. Embodiments can include a home button that can provides function to return to the home screen. Embodiments can include a setting button that provides a function to activate a setting menu. Embodiments can include a stabilizer on/off button that provides a function to activate/deactivate the stabilizer of the patient console 100.
In certain embodiments, a user can move the positioning arm 102 to the required target region by using the positioning arm 102 touchscreen controls. A user can insert the overtube 117 into the patient, and then move the positioning arm 102 to align with the overtube 117. A user can then connect the overtube 117 to the overtube arm 200 and tighten the knobs.
The user can control the positioning arm 102 using the touchscreen controls provided on the patient console 100. The user can push the buttons provided on the touchscreen to move each joint of the positioning arm 102. The positioning arm 102 can provide five degrees of freedom of motion. A user can press and hold the button shown on the touchscreen to move the joint in the specified direction. The user can release the touchscreen button to stop moving the positioning arm 102. Table 1 shows an embodiment of motions provided by each joint J1-J5.
In certain embodiments, a surgeon can control the Joints 4 (e.g., J4) and 5 (e.g., J5) of the positioning arm 102 using hand control device along with an overtube pedal on a surgeon console. Any suitable other control scheme is contemplated herein.
In accordance with at least one aspect of this disclosure, referring to
In accordance with at least one aspect of this disclosure, a method for performing a robotic medical procedure can include using a vertical lift 103 attached to a top of a base 101 of a patient console to provide up and down motion in a vertical axis A1, using a yaw rotation device 105 attached to the top of the vertical lift 103 to provide a yaw rotation about the vertical axis A1, using a pitch rotation device 107 attached to the top of the yaw rotation device 105 and configured to provide a pitch rotation about a pitch axis A2 orthogonal to the vertical axis A1, using a translation device 109 attached to the top of the pitch rotation device 107 and configured to provide sliding translation along a translation axis A3, and using a roll rotation device 111 attached to the translation device 109 to roll relative to the translation device 109 about a roll axis A4 to provide a roll to an instrument controller assembly 113. An angle of the translation axis A3 and the roll axis A4 relative to horizontal can be a function of the pitch rotation provided by the pitch rotation device 107 (about axis A2). A direction of the translation axis A3 and the roll axis A4 can be a function of the yaw rotation about the vertical axis A1 provided by the yaw rotation device 105.
The method can include using an instrument controller assembly 113 having one or more instrument controllers 115 connected to the roll rotation device 111 for controlling a medical device for performing a surgical operation, and using the vertical lift 103, the yaw rotation device 105, the pitch rotation device 107, the translation device 109, and the roll rotation device 111 provide 5-degrees of freedom to the instrument controller assembly 113. The method can include moving the base 101 of the patient console 100 relative to a floor (on which the patient console 100 is standing) to provide an additional degree of freedom of motion. The method can include positioning a medical device for a transanal procedure, a transoral procedure, or a transvaginal procedure.
The method can include controlling each of the vertical lift 103, the yaw rotation device 105, the pitch rotation device 107, the translation device 109, and the roll rotation device 111 with a user input device. The method can include using a graphical user interface (GUI) to control each of the vertical lift 103, the yaw rotation device 105, the pitch rotation device 107, the translation device 109, and the roll rotation device 111. The method can include any other suitable method(s) and/or portion(s) thereof.
As will be appreciated by those skilled in the art, aspects of the present disclosure may be embodied as a system, method or computer program product. Accordingly, aspects of this disclosure may take the form of an entirely hardware embodiment, an entirely software embodiment (including firmware, resident software, micro-code, etc.), or an embodiment combining software and hardware aspects, all possibilities of which can be referred to herein as a “circuit,” “module,” or “system.” A “circuit,” “module,” or “system” can include one or more portions of one or more separate physical hardware and/or software components that can together perform the disclosed function of the “circuit,” “module,” or “system”, or a “circuit,” “module,” or “system” can be a single self-contained unit (e.g., of hardware and/or software). Furthermore, aspects of this disclosure may take the form of a computer program product embodied in one or more computer readable medium(s) having computer readable program code embodied thereon.
Any combination of one or more computer readable medium(s) may be utilized. The computer readable medium may be a computer readable signal medium or a computer readable storage medium. A computer readable storage medium may be, for example, but not limited to, an electronic, magnetic, optical, electromagnetic, infrared, or semiconductor system, apparatus, or device, or any suitable combination of the foregoing. More specific examples (a non-exhaustive list) of the computer readable storage medium would include the following: an electrical connection having one or more wires, a portable computer diskette, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or Flash memory), an optical fiber, a portable compact disc read-only memory (CD-ROM), an optical storage device, a magnetic storage device, or any suitable combination of the foregoing. In the context of this document, a computer readable storage medium may be any tangible medium that can contain, or store a program for use by or in connection with an instruction execution system, apparatus, or device.
A computer readable signal medium may include a propagated data signal with computer readable program code embodied therein, for example, in baseband or as part of a carrier wave. Such a propagated signal may take any of a variety of forms, including, but not limited to, electro-magnetic, optical, or any suitable combination thereof. A computer readable signal medium may be any computer readable medium that is not a computer readable storage medium and that can communicate, propagate, or transport a program for use by or in connection with an instruction execution system, apparatus, or device.
Program code embodied on a computer readable medium may be transmitted using any appropriate medium, including but not limited to wireless, wireline, optical fiber cable, RF, etc., or any suitable combination of the foregoing.
Computer program code for carrying out operations for aspects of this disclosure may be written in any combination of one or more programming languages, including an object oriented programming language such as Java, Smalltalk, C++ or the like and conventional procedural programming languages, such as the “C” programming language or similar programming languages. The program code may execute entirely on the user's computer, partly on the user's computer, as a stand-alone software package, partly on the user's computer and partly on a remote computer or entirely on the remote computer or server. In the latter scenario, the remote computer may be connected to the user's computer through any type of network, including a local area network (LAN) or a wide area network (WAN), or the connection may be made to an external computer (for example, through the Internet using an Internet Service Provider).
Aspects of this disclosure may be described above with reference to flowchart illustrations and/or block diagrams of methods, apparatus (systems) and computer program products according to embodiments of this disclosure. It will be understood that each block of any flowchart illustrations and/or block diagrams, and combinations of blocks in any flowchart illustrations and/or block diagrams, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions/acts specified in any flowchart and/or block diagram block or blocks.
These computer program instructions may also be stored in a computer readable medium that can direct a computer, other programmable data processing apparatus, or other devices to function in a particular manner, such that the instructions stored in the computer readable medium produce an article of manufacture including instructions which implement the function/act specified in the flowchart and/or block diagram block or blocks.
The computer program instructions may also be loaded onto a computer, other programmable data processing apparatus, or other devices to cause a series of operational steps to be performed on the computer, other programmable apparatus or other devices to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide processes for implementing the functions/acts specified herein.
Those having ordinary skill in the art understand that any numerical values disclosed herein can be exact values or can be values within a range. Further, any terms of approximation (e.g., “about”, “approximately”, “around”) used in this disclosure can mean the stated value within a range. For example, in certain embodiments, the range can be within (plus or minus) 20%, or within 10%, or within 5%, or within 2%, or within any other suitable percentage or number as appreciated by those having ordinary skill in the art (e.g., for known tolerance limits or error ranges).
The articles “a”, “an”, and “the” as used herein and in the appended claims are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article unless the context clearly indicates otherwise. By way of example, “an element” means one element or more than one element.
The phrase “and/or,” as used herein in the specification and in the claims, should be understood to mean “either or both” of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases. Multiple elements listed with “and/or” should be construed in the same fashion, i.e., “one or more” of the elements so conjoined. Other elements may optionally be present other than the elements specifically identified by the “and/or” clause, whether related or unrelated to those elements specifically identified. Thus, as a non-limiting example, a reference to “A and/or B”, when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A only (optionally including elements other than B); in another embodiment, to B only (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
As used herein in the specification and in the claims, “or” should be understood to have the same meaning as “and/or” as defined above. For example, when separating items in a list, “or” or “and/or” shall be interpreted as being inclusive, i.e., the inclusion of at least one, but also including more than one, of a number or list of elements, and, optionally, additional unlisted items. Only terms clearly indicated to the contrary, such as “only one of” or “exactly one of,” or, when used in the claims, “consisting of,” will refer to the inclusion of exactly one element of a number or list of elements. In general, the term “or” as used herein shall only be interpreted as indicating exclusive alternatives (i.e., “one or the other but not both”) when preceded by terms of exclusivity, such as “either,” “one of,” “only one of,” or “exactly one of.”
Any suitable combination(s) of any disclosed embodiments and/or any suitable portion(s) thereof are contemplated herein as appreciated by those having ordinary skill in the art in view of this disclosure.
The embodiments of the present disclosure, as described above and shown in the drawings, provide for improvement in the art to which they pertain. While the subject disclosure includes reference to certain embodiments, those skilled in the art will readily appreciate that changes and/or modifications may be made thereto without departing from the spirit and scope of the subject disclosure.
This application is a continuation of International Patent Application No. PCT/US2022/051220 filed Nov. 29, 2022, which claims priority to and the benefit of U.S. Provisional Application No. 63/284,499, filed Nov. 30, 2021, the entire contents of which are herein incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
5792135 | Madhani et al. | Aug 1998 | A |
5797900 | Madhani et al. | Aug 1998 | A |
5976122 | Madhani et al. | Nov 1999 | A |
6063095 | Wang et al. | May 2000 | A |
6132368 | Cooper | Oct 2000 | A |
6244809 | Wang et al. | Jun 2001 | B1 |
6246200 | Blumenkranz et al. | Jun 2001 | B1 |
6312435 | Wallace et al. | Nov 2001 | B1 |
6331181 | Tierney et al. | Dec 2001 | B1 |
6346072 | Cooper | Feb 2002 | B1 |
6364888 | Niemeyer et al. | Apr 2002 | B1 |
6371952 | Madhani et al. | Apr 2002 | B1 |
6394998 | Wallace et al. | May 2002 | B1 |
6424885 | Niemeyer et al. | Jul 2002 | B1 |
6441577 | Blumenkranz et al. | Aug 2002 | B2 |
6451027 | Cooper et al. | Sep 2002 | B1 |
6491691 | Morley et al. | Dec 2002 | B1 |
6491701 | Tierney et al. | Dec 2002 | B2 |
6493608 | Niemeyer | Dec 2002 | B1 |
6522906 | Salisbury, Jr. et al. | Feb 2003 | B1 |
6565554 | Niemeyer | May 2003 | B1 |
6587750 | Gerbi et al. | Jul 2003 | B2 |
6645196 | Nixon et al. | Nov 2003 | B1 |
6671581 | Niemeyer et al. | Dec 2003 | B2 |
6676684 | Morley et al. | Jan 2004 | B1 |
6684129 | Salisbury, Jr. et al. | Jan 2004 | B2 |
6699177 | Wang et al. | Mar 2004 | B1 |
6699235 | Wallace et al. | Mar 2004 | B2 |
6714839 | Salisbury, Jr. et al. | Mar 2004 | B2 |
6746443 | Morley et al. | Jun 2004 | B1 |
6766204 | Niemeyer et al. | Jul 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6785593 | Wang et al. | Aug 2004 | B2 |
6799088 | Wang et al. | Sep 2004 | B2 |
6817972 | Snow | Nov 2004 | B2 |
6817974 | Cooper et al. | Nov 2004 | B2 |
6836703 | Wang et al. | Dec 2004 | B2 |
6837846 | Jaffe et al. | Jan 2005 | B2 |
6840938 | Morley et al. | Jan 2005 | B1 |
6852107 | Wang et al. | Feb 2005 | B2 |
6866671 | Tierney et al. | Mar 2005 | B2 |
6871117 | Wang et al. | Mar 2005 | B2 |
6892112 | Wang et al. | May 2005 | B2 |
6905491 | Wang et al. | Jun 2005 | B1 |
6951535 | Ghodoussi et al. | Oct 2005 | B2 |
6991627 | Madhani et al. | Jan 2006 | B2 |
6994703 | Wang et al. | Feb 2006 | B2 |
7025064 | Wang et al. | Apr 2006 | B2 |
7027892 | Wang et al. | Apr 2006 | B2 |
7048745 | Tierney et al. | May 2006 | B2 |
7066926 | Wallace et al. | Jun 2006 | B2 |
7074179 | Wang et al. | Jul 2006 | B2 |
7083571 | Wang et al. | Aug 2006 | B2 |
7087049 | Nowlin et al. | Aug 2006 | B2 |
7090637 | Danitz et al. | Aug 2006 | B2 |
7118582 | Wang et al. | Oct 2006 | B1 |
7125403 | Julian et al. | Oct 2006 | B2 |
7155315 | Niemeyer et al. | Dec 2006 | B2 |
7204844 | Jensen et al. | Apr 2007 | B2 |
7276065 | Morley et al. | Oct 2007 | B2 |
7320700 | Cooper et al. | Jan 2008 | B2 |
7331967 | Lee et al. | Feb 2008 | B2 |
7333642 | Green | Feb 2008 | B2 |
7357774 | Cooper | Apr 2008 | B2 |
7398707 | Morley et al. | Jul 2008 | B2 |
7524320 | Tierney et al. | Apr 2009 | B2 |
7574250 | Niemeyer | Aug 2009 | B2 |
7608083 | Lee et al. | Oct 2009 | B2 |
7615066 | Danitz et al. | Nov 2009 | B2 |
7691098 | Wallace et al. | Apr 2010 | B2 |
7744608 | Lee et al. | Jun 2010 | B2 |
7756036 | Druke et al. | Jul 2010 | B2 |
7757028 | Druke et al. | Jul 2010 | B2 |
7763015 | Cooper et al. | Jul 2010 | B2 |
7780651 | Madhani et al. | Aug 2010 | B2 |
7837674 | Cooper | Nov 2010 | B2 |
7854738 | Lee et al. | Dec 2010 | B2 |
7865266 | Moll et al. | Jan 2011 | B2 |
7955322 | Devengenzo et al. | Jun 2011 | B2 |
8052636 | Moll et al. | Nov 2011 | B2 |
8054752 | Druke et al. | Nov 2011 | B2 |
8068649 | Green | Nov 2011 | B2 |
8075474 | Honda et al. | Dec 2011 | B2 |
8100133 | Mintz et al. | Jan 2012 | B2 |
8120301 | Goldberg et al. | Feb 2012 | B2 |
8123740 | Madhani et al. | Feb 2012 | B2 |
8147503 | Zhao et al. | Apr 2012 | B2 |
8169468 | Scott et al. | May 2012 | B2 |
8182415 | Larkin et al. | May 2012 | B2 |
8190238 | Moll et al. | May 2012 | B2 |
8228368 | Zhao et al. | Jul 2012 | B2 |
8323297 | Hinman et al. | Dec 2012 | B2 |
8335590 | Costa et al. | Dec 2012 | B2 |
8337521 | Cooper et al. | Dec 2012 | B2 |
8343045 | Swinehart et al. | Jan 2013 | B2 |
8343141 | Madhani et al. | Jan 2013 | B2 |
8365633 | Simaan et al. | Feb 2013 | B2 |
8375808 | Blumenkranz et al. | Feb 2013 | B2 |
8398541 | DiMaio et al. | Mar 2013 | B2 |
8437629 | McDowall | May 2013 | B2 |
8469947 | Devengenzo et al. | Jun 2013 | B2 |
8475366 | Boulais et al. | Jul 2013 | B2 |
8506555 | Ruiz Morales | Aug 2013 | B2 |
8594841 | Zhao et al. | Nov 2013 | B2 |
8597280 | Cooper et al. | Dec 2013 | B2 |
8600551 | Itkowitz et al. | Dec 2013 | B2 |
8617102 | Moll et al. | Dec 2013 | B2 |
8644988 | Prisco et al. | Feb 2014 | B2 |
8679099 | Cooper et al. | Mar 2014 | B2 |
8690908 | Cooper et al. | Apr 2014 | B2 |
8709000 | Madhani et al. | Apr 2014 | B2 |
8740885 | Larkin et al. | Jun 2014 | B2 |
8784435 | Cooper et al. | Jul 2014 | B2 |
8786241 | Nowlin et al. | Jul 2014 | B2 |
8790243 | Cooper et al. | Jul 2014 | B2 |
8801661 | Moll et al. | Aug 2014 | B2 |
8810631 | Scott et al. | Aug 2014 | B2 |
8816628 | Nowlin et al. | Aug 2014 | B2 |
8821480 | Burbank | Sep 2014 | B2 |
8831782 | Itkowitz | Sep 2014 | B2 |
8838270 | Druke et al. | Sep 2014 | B2 |
8852208 | Gomez et al. | Oct 2014 | B2 |
8887595 | Williams | Nov 2014 | B2 |
8888690 | Swinehart et al. | Nov 2014 | B2 |
8888764 | Devengenzo et al. | Nov 2014 | B2 |
8903549 | Itkowitz et al. | Dec 2014 | B2 |
8918207 | Prisco | Dec 2014 | B2 |
8944070 | Guthart et al. | Feb 2015 | B2 |
8945095 | Blumenkranz et al. | Feb 2015 | B2 |
9011318 | Choset et al. | Apr 2015 | B2 |
9050120 | Swarup et al. | Jun 2015 | B2 |
9060678 | Larkin et al. | Jun 2015 | B2 |
9089354 | Simaan et al. | Jul 2015 | B2 |
9095362 | Dachs, II et al. | Aug 2015 | B2 |
9138284 | Krom et al. | Sep 2015 | B2 |
9144456 | Rosa et al. | Sep 2015 | B2 |
9186221 | Burbank | Nov 2015 | B2 |
9254090 | Watson et al. | Feb 2016 | B2 |
9259274 | Prisco | Feb 2016 | B2 |
9259276 | Mintz et al. | Feb 2016 | B2 |
9301807 | Duval | Apr 2016 | B2 |
9308937 | Griffiths et al. | Apr 2016 | B2 |
9339341 | Cooper | May 2016 | B2 |
9358074 | Schena et al. | Jun 2016 | B2 |
9456839 | Cooper | Oct 2016 | B2 |
9486288 | Devengenzo et al. | Nov 2016 | B2 |
9498242 | Crews et al. | Nov 2016 | B2 |
9504517 | Rosa et al. | Nov 2016 | B2 |
9510915 | Madhani et al. | Dec 2016 | B2 |
9565990 | Lee et al. | Feb 2017 | B2 |
9687310 | Nowlin et al. | Jun 2017 | B2 |
9717486 | Cooper et al. | Aug 2017 | B2 |
9757149 | Cooper et al. | Sep 2017 | B2 |
9757203 | Hourtash et al. | Sep 2017 | B2 |
9775678 | Lohmeier | Oct 2017 | B2 |
9782056 | McDowall | Oct 2017 | B2 |
9782225 | Lohmeier et al. | Oct 2017 | B2 |
9795446 | DiMaio et al. | Oct 2017 | B2 |
9795453 | Tierney et al. | Oct 2017 | B2 |
9801526 | Larkin et al. | Oct 2017 | B2 |
9801654 | Gomez et al. | Oct 2017 | B2 |
9814527 | Rogers et al. | Nov 2017 | B2 |
9877794 | Csiky | Jan 2018 | B2 |
9901402 | Itkowitz et al. | Feb 2018 | B2 |
9918659 | Chopra et al. | Mar 2018 | B2 |
9949620 | Duval et al. | Apr 2018 | B2 |
9962066 | Rogers et al. | May 2018 | B2 |
9968405 | Cooper et al. | May 2018 | B2 |
9980630 | Larkin et al. | May 2018 | B2 |
10010331 | Morash | Jul 2018 | B2 |
10039473 | Zhao et al. | Aug 2018 | B2 |
10058390 | Simaan et al. | Aug 2018 | B2 |
10085788 | Privitera et al. | Oct 2018 | B2 |
10085806 | Hagn et al. | Oct 2018 | B2 |
10092172 | Peh et al. | Oct 2018 | B2 |
10105128 | Cooper et al. | Oct 2018 | B2 |
10117715 | Lohmeier et al. | Nov 2018 | B2 |
10159536 | Kralicky et al. | Dec 2018 | B2 |
10178368 | Zhao et al. | Jan 2019 | B2 |
10179024 | Yeung | Jan 2019 | B2 |
10179413 | Rockrohr | Jan 2019 | B2 |
10188472 | Diolaiti et al. | Jan 2019 | B2 |
10258421 | Lohmeier et al. | Apr 2019 | B2 |
10278782 | Jarc et al. | May 2019 | B2 |
10321964 | Grover et al. | Jun 2019 | B2 |
10327856 | Kralicky et al. | Jun 2019 | B2 |
10363107 | Blumenkranz et al. | Jul 2019 | B2 |
10365295 | Blumenkranz et al. | Jul 2019 | B2 |
10390687 | Choi et al. | Aug 2019 | B2 |
10390895 | Henderson et al. | Aug 2019 | B2 |
10391635 | Berghofer et al. | Aug 2019 | B2 |
10398520 | Larkin et al. | Sep 2019 | B2 |
10413370 | Yates et al. | Sep 2019 | B2 |
10448813 | Cooper et al. | Oct 2019 | B2 |
10456166 | Cooper et al. | Oct 2019 | B2 |
10507068 | Kopp et al. | Dec 2019 | B2 |
10512481 | Cooper | Dec 2019 | B2 |
10524644 | Scott et al. | Jan 2020 | B2 |
10524868 | Cooper et al. | Jan 2020 | B2 |
10531929 | Widenhouse et al. | Jan 2020 | B2 |
10602958 | Silverstein et al. | Mar 2020 | B2 |
10646990 | Olds et al. | May 2020 | B2 |
10660713 | McCrea et al. | May 2020 | B2 |
10682193 | Choi et al. | Jun 2020 | B2 |
10729503 | Cameron | Aug 2020 | B2 |
10736702 | Harris et al. | Aug 2020 | B2 |
10779896 | Dachs, II et al. | Sep 2020 | B2 |
10779899 | Griffiths et al. | Sep 2020 | B2 |
10786329 | Schuh et al. | Sep 2020 | B2 |
10820953 | Kralicky et al. | Nov 2020 | B2 |
10828115 | Koenig et al. | Nov 2020 | B2 |
10828117 | Evans | Nov 2020 | B2 |
10835331 | Burbank | Nov 2020 | B2 |
10835335 | Perdue et al. | Nov 2020 | B2 |
10856946 | Solomon et al. | Dec 2020 | B2 |
10864051 | Simi et al. | Dec 2020 | B2 |
10874475 | Iceman | Dec 2020 | B2 |
10881422 | Kim et al. | Jan 2021 | B2 |
10898189 | McDonald, II | Jan 2021 | B2 |
10898281 | Cooper et al. | Jan 2021 | B2 |
10905505 | Barakat et al. | Feb 2021 | B1 |
10918449 | Solomon et al. | Feb 2021 | B2 |
10939970 | Laakso et al. | Mar 2021 | B2 |
10959607 | Rogers et al. | Mar 2021 | B2 |
11037464 | Ho et al. | Jun 2021 | B2 |
20020161281 | Jaffe et al. | Oct 2002 | A1 |
20030036748 | Cooper et al. | Feb 2003 | A1 |
20030083673 | Tierney et al. | May 2003 | A1 |
20030114962 | Niemeyer | Jun 2003 | A1 |
20030135203 | Wang et al. | Jul 2003 | A1 |
20040049205 | Lee et al. | Mar 2004 | A1 |
20040138700 | Cooper et al. | Jul 2004 | A1 |
20040162547 | Wallace et al. | Aug 2004 | A1 |
20040236316 | Danitz et al. | Nov 2004 | A1 |
20050043718 | Madhani et al. | Feb 2005 | A1 |
20050059960 | Simaan et al. | Mar 2005 | A1 |
20050149003 | Tierney et al. | Jul 2005 | A1 |
20050200324 | Guthart et al. | Sep 2005 | A1 |
20050204851 | Morley et al. | Sep 2005 | A1 |
20050216033 | Lee et al. | Sep 2005 | A1 |
20050251112 | Danitz et al. | Nov 2005 | A1 |
20060167440 | Cooper et al. | Jul 2006 | A1 |
20070043338 | Moll et al. | Feb 2007 | A1 |
20070137372 | Devengenzo et al. | Jun 2007 | A1 |
20070151390 | Blumenkranz et al. | Jul 2007 | A1 |
20070156119 | Wallace et al. | Jul 2007 | A1 |
20070156122 | Cooper | Jul 2007 | A1 |
20070197896 | Moll et al. | Aug 2007 | A1 |
20080065105 | Larkin et al. | Mar 2008 | A1 |
20080065107 | Larkin et al. | Mar 2008 | A1 |
20080065111 | Blumenkranz et al. | Mar 2008 | A1 |
20080071291 | Duval et al. | Mar 2008 | A1 |
20080077159 | Madhani et al. | Mar 2008 | A1 |
20080177282 | Lee et al. | Jul 2008 | A1 |
20080177284 | Lee et al. | Jul 2008 | A1 |
20080287963 | Rogers et al. | Nov 2008 | A1 |
20090023989 | Honda et al. | Jan 2009 | A1 |
20090171151 | Choset et al. | Jul 2009 | A1 |
20100011901 | Burbank | Jan 2010 | A1 |
20100048999 | Boulais et al. | Feb 2010 | A1 |
20100082041 | Prisco | Apr 2010 | A1 |
20100234831 | Hinman et al. | Sep 2010 | A1 |
20100274087 | Diolaiti et al. | Oct 2010 | A1 |
20100292708 | Madhani et al. | Nov 2010 | A1 |
20110118755 | Cooper et al. | May 2011 | A1 |
20110125166 | Cooper et al. | May 2011 | A1 |
20110144658 | Wenderow et al. | Jun 2011 | A1 |
20110152879 | Williams | Jun 2011 | A1 |
20110196419 | Cooper | Aug 2011 | A1 |
20110277580 | Cooper et al. | Nov 2011 | A1 |
20110282351 | Cooper et al. | Nov 2011 | A1 |
20110282359 | Duval | Nov 2011 | A1 |
20110282491 | Prisco et al. | Nov 2011 | A1 |
20110288561 | Devengenzo et al. | Nov 2011 | A1 |
20110313449 | Cooper | Dec 2011 | A1 |
20120150192 | Dachs, II et al. | Jun 2012 | A1 |
20120203271 | Larkin et al. | Aug 2012 | A1 |
20120209174 | Moll et al. | Aug 2012 | A1 |
20120221011 | Larkin et al. | Aug 2012 | A1 |
20120232339 | Csiky | Sep 2012 | A1 |
20130053868 | Cooper et al. | Feb 2013 | A1 |
20130079794 | Cooper et al. | Mar 2013 | A9 |
20130096540 | Cooper et al. | Apr 2013 | A1 |
20130110131 | Madhani et al. | May 2013 | A1 |
20130197539 | Simaan et al. | Aug 2013 | A1 |
20130197540 | Simaan et al. | Aug 2013 | A1 |
20130267950 | Rosa et al. | Oct 2013 | A1 |
20130267964 | Rogers et al. | Oct 2013 | A1 |
20130274761 | Devengenzo et al. | Oct 2013 | A1 |
20140081292 | Moll et al. | Mar 2014 | A1 |
20140194899 | Madhani et al. | Jul 2014 | A1 |
20140243852 | Cooper et al. | Aug 2014 | A1 |
20140257336 | Choi et al. | Sep 2014 | A1 |
20140277106 | Crews et al. | Sep 2014 | A1 |
20140296637 | Lee et al. | Oct 2014 | A1 |
20140296872 | Cooper et al. | Oct 2014 | A1 |
20150066002 | Cooper et al. | Mar 2015 | A1 |
20150100066 | Kostrzewski et al. | Apr 2015 | A1 |
20150150636 | Hagn et al. | Jun 2015 | A1 |
20150173726 | Lohmeier et al. | Jun 2015 | A1 |
20150173729 | Lohmeier et al. | Jun 2015 | A1 |
20150173731 | Lohmeier et al. | Jun 2015 | A1 |
20150173840 | Lohmeier | Jun 2015 | A1 |
20150238267 | Devengenzo et al. | Aug 2015 | A1 |
20150250546 | Larkin et al. | Sep 2015 | A1 |
20160015447 | Rosa et al. | Jan 2016 | A1 |
20160058512 | Gomez et al. | Mar 2016 | A1 |
20160066773 | Cooper et al. | Mar 2016 | A1 |
20160242860 | Diolaiti et al. | Aug 2016 | A1 |
20160256183 | Cooper | Sep 2016 | A1 |
20170014197 | McCrea et al. | Jan 2017 | A1 |
20170020615 | Koenig et al. | Jan 2017 | A1 |
20170071628 | Cooper et al. | Mar 2017 | A1 |
20170112505 | Morash | Apr 2017 | A1 |
20170156804 | Cooper et al. | Jun 2017 | A1 |
20170265923 | Privitera et al. | Sep 2017 | A1 |
20170273749 | Grover et al. | Sep 2017 | A1 |
20170274533 | Berghofer et al. | Sep 2017 | A1 |
20170281296 | Cooper et al. | Oct 2017 | A1 |
20170312043 | Ogawa et al. | Nov 2017 | A1 |
20170325879 | Yeung | Nov 2017 | A1 |
20170354318 | Rogers et al. | Dec 2017 | A1 |
20170367775 | Dachs, II et al. | Dec 2017 | A1 |
20170367777 | Kralicky et al. | Dec 2017 | A1 |
20180000318 | Rogers et al. | Jan 2018 | A9 |
20180000548 | Olds et al. | Jan 2018 | A1 |
20180014852 | Gomez et al. | Jan 2018 | A1 |
20180049820 | Widenhouse et al. | Feb 2018 | A1 |
20180049822 | Henderson et al. | Feb 2018 | A1 |
20180049827 | Harris et al. | Feb 2018 | A1 |
20180064498 | Kapadia et al. | Mar 2018 | A1 |
20180111273 | Linnell et al. | Apr 2018 | A1 |
20180132956 | Cameron | May 2018 | A1 |
20180168747 | Kopp et al. | Jun 2018 | A1 |
20180168752 | Scheib et al. | Jun 2018 | A1 |
20180193007 | Au et al. | Jul 2018 | A1 |
20180200894 | Rockrohr | Jul 2018 | A1 |
20180214176 | Solomon et al. | Aug 2018 | A1 |
20180221096 | Yates et al. | Aug 2018 | A1 |
20180242824 | Larkin et al. | Aug 2018 | A1 |
20180256270 | Cooper et al. | Sep 2018 | A1 |
20180271607 | Kralicky et al. | Sep 2018 | A1 |
20180271616 | Schuh et al. | Sep 2018 | A1 |
20180286287 | Razzaque | Oct 2018 | A1 |
20180296299 | Iceman | Oct 2018 | A1 |
20180317915 | McDonald, II | Nov 2018 | A1 |
20180318023 | Griffiths et al. | Nov 2018 | A1 |
20180353204 | Solomon et al. | Dec 2018 | A1 |
20180370045 | Kan | Dec 2018 | A1 |
20190039241 | Langenfeld et al. | Feb 2019 | A1 |
20190117247 | Kim et al. | Apr 2019 | A1 |
20190125467 | Evans | May 2019 | A1 |
20190216551 | Burbank | Jul 2019 | A1 |
20190269472 | Kralicky et al. | Sep 2019 | A1 |
20190274769 | Perdue et al. | Sep 2019 | A1 |
20190314645 | Ciresianu et al. | Oct 2019 | A1 |
20190328472 | Tojo et al. | Oct 2019 | A1 |
20190380801 | Savall et al. | Dec 2019 | A1 |
20200038123 | Graetzel et al. | Feb 2020 | A1 |
20200069389 | Morrissette et al. | Mar 2020 | A1 |
20200078097 | Gregerson et al. | Mar 2020 | A1 |
20200107898 | Kim et al. | Apr 2020 | A1 |
20200146763 | Schena et al. | May 2020 | A1 |
20200179067 | Ross et al. | Jun 2020 | A1 |
20200205917 | Peine et al. | Jul 2020 | A1 |
20200214774 | Yoshida et al. | Jul 2020 | A1 |
20200297444 | Camarillo et al. | Sep 2020 | A1 |
20200315645 | Kim et al. | Oct 2020 | A1 |
20200330173 | Kapadia et al. | Oct 2020 | A1 |
20200367979 | Laakso et al. | Nov 2020 | A1 |
20200397456 | Kim et al. | Dec 2020 | A1 |
20200397457 | Kim et al. | Dec 2020 | A1 |
20210045819 | Castillo et al. | Feb 2021 | A1 |
20210077195 | Saeidi et al. | Mar 2021 | A1 |
20210241542 | Shmayahu et al. | Aug 2021 | A1 |
20210259794 | Kato et al. | Aug 2021 | A1 |
20210267702 | Kim et al. | Sep 2021 | A1 |
20210275266 | Kim et al. | Sep 2021 | A1 |
20210322045 | Kim et al. | Oct 2021 | A1 |
20210322046 | Kim et al. | Oct 2021 | A1 |
20210338052 | Ouyang et al. | Nov 2021 | A1 |
20220354524 | Kim et al. | Nov 2022 | A1 |
20230210618 | Kim et al. | Jul 2023 | A1 |
20230210621 | Noh et al. | Jul 2023 | A1 |
20230248419 | Cho et al. | Aug 2023 | A1 |
20230248450 | Ravi et al. | Aug 2023 | A1 |
20230248457 | Lee et al. | Aug 2023 | A1 |
20230255702 | Park et al. | Aug 2023 | A1 |
20230285090 | Lee et al. | Sep 2023 | A1 |
20230285099 | Lee et al. | Sep 2023 | A1 |
20230355221 | Shin et al. | Nov 2023 | A1 |
20230363842 | Choi et al. | Nov 2023 | A1 |
20230363847 | Lee et al. | Nov 2023 | A1 |
20240058079 | Kim et al. | Feb 2024 | A1 |
Number | Date | Country |
---|---|---|
105310775 | Feb 2016 | CN |
108309370 | Jul 2018 | CN |
109674647 | Apr 2019 | CN |
213606867 | Jul 2021 | CN |
2968048 | Jun 2018 | EP |
3175813 | Jan 2020 | EP |
2019530517 | Oct 2019 | JP |
2020104843 | Jul 2020 | JP |
2021513442 | May 2021 | JP |
20110032444 | Mar 2011 | KR |
101943440 | Jan 2019 | KR |
2012035492 | Mar 2012 | WO |
2016109886 | Jul 2016 | WO |
2019055681 | Mar 2019 | WO |
2020243285 | Dec 2020 | WO |
2021026231 | Feb 2021 | WO |
2021071540 | Apr 2021 | WO |
2021161162 | Aug 2021 | WO |
2021161184 | Aug 2021 | WO |
Entry |
---|
“Plenary 1: Colubris MX”—YouTube Video link address https://www.youtube.com/watch?v=in_IuQiAZg8 dated Aug. 20, 2020. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051217. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051220. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 7, 2023, in corresponding International Patent Application PCT/US2022/051225. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051237. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051246. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051255. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051259. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051261. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 14, 2023, in corresponding International Patent Application PCT/US2022/051265. |
International Search Report and Written Opinion, of the Korean Intellectual Property Office, as ISA, mailed Apr. 6, 2023, in corresponding International Patent Application PCT/US2022/051262. |
Office Action mailed Jun. 16, 2023, issued for Taiwanese Patent Application No. 111145621 and English translation of the Search Report. |
Number | Date | Country | |
---|---|---|---|
20230285098 A1 | Sep 2023 | US |
Number | Date | Country | |
---|---|---|---|
63284499 | Nov 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2022/051220 | Nov 2022 | WO |
Child | 18122007 | US |